Multi-cancer early detection (MCED) testing is generating significant excitement—but what does the evidence actually support? In this data-driven session, Dr. Candace Westgate will review the current science behind MCED technologies, including test performance, clinical utility, and implementation challenges. Drawing on her experience integrating preventive tools into practice, she’ll explore where MCED testing fits into the future of cancer screening and how clinicians can approach its use with clarity and caution.

Candace Westgate, DO, FACOG, is a board-certified OB/GYN and Lifestyle Medicine physician specializing in preventive care and early cancer detection. She was the Medical Director of the Adventist Health AHEAD (All-Around Early Detection) Program, one of the nation’s first community-based initiatives to offer multi-cancer detection testing and is now the Director of Personalized Medicine at Community Health. Dr. Westgate is passionate about empowering patients with innovative tools to take charge of their health and catch cancer early—when it’s most treatable.